AEHR (AEHR) director Laura Oliphant receives 1,658-share restricted stock grant

Rhea-AI Filing Summary

AEHR TEST SYSTEMS director Laura Oliphant received an equity award of 1,658 shares of common stock as a grant or award. The shares were acquired at a stated price of $0.00 per share and are structured as restricted stock units.

After this award, Oliphant directly holds 18,317 shares of common stock, which includes shares subject to unvested restricted stock units. One-fourth of the total restricted stock unit award vests at the end of each three full calendar months following the grant date, as long as she continues to serve on the company’s Board of Directors.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider OLIPHANT LAURA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,658	$0.00	--

Holdings After Transaction: Common Stock — 18,317 shares (Direct)

Footnotes (1)

1. One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. The amount reported includes shares subject to unvested restricted stock units.

Key Figures

Shares granted: 1,658 shares Grant price: $0.00 per share Total holdings after grant: 18,317 shares +2 more

5 metrics

Shares granted 1,658 shares Restricted stock unit award of common stock

Grant price $0.00 per share Stated transaction price for RSU grant

Total holdings after grant 18,317 shares Direct common stock holdings following transaction

Vesting schedule fraction 1/4 of award Vests every three full calendar months

Vesting interval Every three full calendar months RSU vesting timing, subject to continued Board service

Key Terms

restricted stock unit, vest, Board of Director, unvested restricted stock units

4 terms

restricted stock unit financial

"shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

vest financial

"shall vest at the end of each three full calendar months following the date of this action"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Board of Director financial

"provided that such recipient still serves as a member of the Board of Director of the corporation"

unvested restricted stock units financial

"The amount reported includes shares subject to unvested restricted stock units."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 05:27 PM Accepted by SEC EDGAR 07/02/2026 - 05:26 PM Learn about SEC filing dates

FAQ

What did AEHR (AEHR) director Laura Oliphant report in this Form 4?

Laura Oliphant reported receiving 1,658 shares of AEHR common stock as an equity grant. The award is structured as restricted stock units and was reported at a price of $0.00 per share, increasing her direct holdings to 18,317 shares in total.

How many AEHR (AEHR) shares were granted to Laura Oliphant?

Laura Oliphant was granted 1,658 shares of AEHR common stock in the form of restricted stock units. These shares were recorded at a transaction price of $0.00 per share and form part of her updated total direct holdings of 18,317 shares.

What is Laura Oliphant’s total AEHR (AEHR) shareholding after this transaction?

After the reported transaction, Laura Oliphant directly holds 18,317 AEHR common shares. This total includes shares subject to unvested restricted stock units, meaning some of these shares will vest over time as she continues serving on the Board of Directors.

How do the restricted stock units granted to AEHR (AEHR) director Laura Oliphant vest?

The restricted stock units vest in four equal parts over time. One-fourth of the total shares vests at the end of each three full calendar months after the grant date, provided she continues to serve as a member of AEHR’s Board of Directors on those dates.

Were the AEHR (AEHR) shares granted to Laura Oliphant purchased on the open market?

No, the 1,658 AEHR shares were not an open-market purchase; they were granted as an equity award. The Form 4 identifies the transaction code as a grant or award acquisition, with a transaction price of $0.00 per share for this non-derivative common stock.

Does Laura Oliphant’s reported AEHR (AEHR) holding include unvested restricted stock units?

Yes, her reported total of 18,317 AEHR shares includes unvested restricted stock units. A footnote clarifies that the amount reported includes shares subject to unvested restricted stock unit awards, which will continue to vest as she remains on the Board.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OLIPHANT LAURA

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CALIFORNIA 94539

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		1,658(1)	A	$0	18,317(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.

2. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)